Sonographically detectable clips were introduced over the last decade. We retrospectively studied the rate and duration of sonographically detectable clip detectability in patients with breast cancer who had sonographically detectable clips inserted over a 2-year period. Nine of 26 patients had neoadjuvant chemotherapy, with all clips remaining detectable 140 to 187 days after insertion. Six of the 9 had intraoperative sonographic localization, with 1 reoperation (17%). Eleven additional patients with nonpalpable tumors and sonographically detectable clips had intraoperative sonographic localization with 1 reoperation (9%). In 1 patient, a sonographically detectable clip enabled intraoperative identification of a suspicious lymph node. There were no complications or clip migration. Sonographically detectable clips are helpful in breast cancer surgery with and without neoadjuvant chemotherapy, remaining detectable for many months and often averting preoperative localization and scheduling difficulties.
Sonographically detectable clips were introduced over the last decade. We retrospectively studied the rate and duration of sonographically detectable clip detectability in patients with breast cancer who had sonographically detectable clips inserted over a 2-year period. Nine of 26 patients had neoadjuvant chemotherapy, with all clips remaining detectable 140 to 187 days after insertion. Six of the 9 had intraoperative sonographic localization, with 1 reoperation (17%). Eleven additional patients with nonpalpable tumors and sonographically detectable clips had intraoperative sonographic localization with 1 reoperation (9%). In 1 patient, a sonographically detectable clip enabled intraoperative identification of a suspicious lymph node. There were no complications or clip migration. Sonographically detectable clips are helpful in breast cancer surgery with and without neoadjuvant chemotherapy, remaining detectable for many months and often averting preoperative localization and scheduling difficulties.
Key Words-biopsy marker clips; breast cancer; breast ultrasound; localization; sonographically detectable clips P ercutaneous image-guided biopsy is the primary means for diagnosis of abnormal findings in the breast. With improvements in early detection, breast lesions have become smaller and more are nonpalpable. These advances have resulted mainly from the proliferation of screening in populations at increased risk that have become more well defined, as well as in the general population. The technologic improvements in mammography, together with the introduction of additional modalities such as breast sonography and breast magnetic resonance imaging (MRI) for screening purposes, have improved the quality of imaging and the ability to identify suspicious lesions, including those in younger women with dense breasts. Very small lesions are no longer rare, and the rate of nonpalpable cancers is approaching 50% of patients in many centers and continuing to grow. 1 Metal clips to mark biopsy sites were introduced in the late 1990s.
2 These are helpful in a variety of situations. Clips can mark the site of a lesion diagnosed by vacuum-assisted biopsy, a procedure that may entirely remove the lesion, 3 making localization for surgery or follow-up difficult. In such cases, localization according to the site of hematoma is a possibility. 4 However, the frequently large size of the hematoma and its disappearance over time may cause difficulties in tumor localization.
Clip deployment after biopsy can enable better correlation across different imaging modalities, such as determining whether lesions detected by two different modalities are the same single lesion or separate lesions. Clip insertion before neoadjuvant treatment can enable preservation of the tumor site for localization in case of a radiologic complete response. Additionally, clips may help in differentiating between biopsied lesions and any additional adjacent abnormalities.
Nonpalpable breast abnormalities that require surgery commonly undergo preoperative wire localization, which is performed by the radiologist, preferably under ultrasound guidance.
1 Localization is performed with mammography if the lesion cannot be visualized by sonography. After biopsies performed with MRI, localization is mammographically guided by the clip that was placed during the MRI-guided biopsy or guided by MRI if biopsy and clip placement were not possible. Wire localization is uncomfortable, is stressful to the patient, and requires that localization by the radiologist be scheduled close to the time of surgery, which may be cumbersome.
Sonographically detectable clips have been available for more than a decade. 5 They increase the options available to the breast radiologist, simplifying needle localization by enabling it to be done with the use of sonography rather than mammography in many cases. With the introduction of intraoperative breast sonography in many centers, 6 sonographically detectable clips also enhance the ability of the breast surgeon to benefit from the use of intraoperative sonography for lesions that would not otherwise be detectable by sonography. 7 In our breast unit, sonography is routinely used by surgeons in outpatient clinics as well as intraoperatively for tumor localization and margin assessment ( Figure  1 ). The purpose of this study was to review the settings in which sonographically detectable clips were used in our service and to assess their rate of detection, the time they remained detectable by sonography, and advantages and drawbacks of their use.
Materials and Methods
Institutional Review Board authorization was obtained, and informed consent was waived. Over 2 years, 572 new patients had breast cancer surgery in the Shaare Zedek Medical Center Breast Unit. All patients are entered in our breast cancer registry. The study included all patients who had sonographically detectable clips inserted preoperatively. Clips were placed in tumors by the radiologist at biopsy or before neoadjuvant chemotherapy or by the surgeon during sentinel node biopsy before neoadjuvant chemotherapy. The only sonographically detectable clip used was the HydroMARK clip (Biopsy Sciences, Clearwater, FL). In patients receiving neoadjuvant chemotherapy, interval sonographic examinations were performed for follow-up of the tumor and clip. All patients had a sonographic examination during the clinic visit before their operation to verify clip visibility and to rule out clip migration. The position of the clip was verified preoperatively by sonography using breast coordinates (clock position and distance from the nipple) compared with previous sonograms or by joint imaging by the surgeon and the radiologist.
After preparing and draping the surgical field, the surgeon performed sonography to localize the clip. A localization needle was inserted percutaneously, or the tumor was resected without a localization needle, according to the surgeon's preference, with ultrasound guidance in both instances. After the lumpectomy specimen was removed, the presence of the clip was confirmed intraoperatively with sonography by the surgeon. When relevant, margins were also assessed by sonography. Radiographs of the specimens were initially obtained in all patients but later only in those with mammographic findings such as ductal carcinoma in situ in the vicinity of the tumor.
Results
Twenty-nine female patients had surgery for breast cancer with a previously deployed sonographically detectable clip over 2 years. In 3 of these patients, surgery was performed shortly after diagnosis without neoadjuvant chemotherapy, and the clip did not serve for intraoperative sonography by the surgeon. The mean patient age was 55.3 years (range, 32.0-80.0 years). The mean tumor diameter, as assessed sonographically, was 7.4 mm (range, 5.0-15.0 mm), and the pathologic diameter was 9.5 mm (range, 2.3-19.0 mm). The mean tumor diameter in the patients who had neoadjuvant chemotherapy was 40.6 mm (range, 22.0-70.0 mm) before treatment. The mean pathologic tumor diameter after chemotherapy was 24.0 mm (range, 8.0-42.0 mm) in the patients who had breast conservation. In 26 patients, the clips were visualized or served for localization with or without neoadjuvant chemotherapy. Figure 1 shows how sonographically detectable clips were used in these 26 patients. Radiologists deployed the clips in 19 patients. Two had clip deployment before neoadjuvant treatment, and 1 had a clip inserted into a suspicious lymph node. In 16 patients, the lesions were small and nonpalpable and had a clip inserted by the radiologist in the course of a biopsy. In 4 of the 16 patients, the clips were not used by the surgeon for intraoperative tumor identification, and wire localization was performed preoperatively by the radiologist. In an additional patient, 2 bracketing clips were inserted during stereotactic biopsy for calcifications that were proven to be ductal carcinoma in situ, which were not detected by sonography, and wire localization was done by the radiologist under ultrasound guidance preoperatively, with intraoperative sonography by the surgeon, resulting in clear surgical margins. In the other 11 patients who had nonpalpable breast carcinoma (10 invasive tumors and 1 ductal carcinoma in situ that had clip insertion at stereotactic biopsy), the tumor was localized intraoperatively under sonography by the surgeon. In 1 of these, a clip was placed in a finding diagnosed as atypical ductal hyperplasia adjacent to a known carcinoma. One patient (9%) had involved margins and underwent a relumpectomy.
The patient mentioned above, with a suspicious axillary node that was not metastatic at core biopsy who had a sonographically detectable clip placed by the radiologist at the surgeon's request, also had lymphatic mapping with a radioactive tracer. Intraoperative ultrasoundguided excision of the lymph node was performed, which was also a radioactive sentinel node and contained a metastasis.
In 7 other patients, the clip was inserted into the tumor by the surgeon. This procedure was done under general anesthesia during sentinel lymph node biopsy in patients with negative axillary sonographic findings before neoadjuvant chemotherapy.
Of the 9 patients who had neoadjuvant chemotherapy (2 with clips inserted by the radiologist and 7 by the surgeon), 3 eventually had mastectomies. In 1 patient, this course was chosen because of failure to respond to treatment and a large tumor. Two other patients elected to have mastectomy. One of them was found to be a carrier of a BRCA1 mutation and had bilateral surgery, and 1 had additional equivocal mammographic findings. Both had a pathologic complete response. Of the 6 patients who had breast-conserving treatment after neoadjuvant chemotherapy, intraoperative sonography was used to localize the tumor in 5. In 1 patient, the response to chemotherapy was minimal, but intraoperative sonography was used to visualize the 2 sonographically detectable clips at the periphery of the tumor to aid in delineation of resection margins. In 1 patient, in whom the response to treatment was patchy, margins were involved (17%), and the patient had a successful relumpectomy.
In all patients with sonographically detectable clips, the clips were readily visualized by the surgeon. In the 9 patients who had neoadjuvant chemotherapy, the operations were performed 140 to 187 days after clip insertion, and the clips were all visualized again immediately before and at surgery without difficulty. There were no complications related to clip deployment and no instances of clip migration. Figure 2 shows clip insertion under sonography. Figure 3 shows a residual tumor after chemotherapy before surgery with the HydroMARK clip in it. Figure 4 shows intraoperative clip visibility in a specimen. Figure  5 shows a radiograph of a surgical specimen with a clip in it. Figures 6 and 7 show HydroMARK clips visualized by preoperative mammography and by intraoperative sonography in a metastatic axillary lymph node.
Discussion
Intraoperative use of sonography by surgeons enables intraoperative localization of lesions and reduces the rate of involved surgical margins. 8 It is becoming routine in some breast centers. 6 In this study, sonographically detectable clips were used intraoperatively to guide surgery of nonpalpable tumors, for the presence of multiple sonographic findings, for tumors undergoing surgery after neoadjuvant chemotherapy, and for identification of a suspicious nonpalpable lymph node. Success rates were high for both identification and obtaining clear margins, without any untoward effects. It should be borne in mind that this series was small and does not enable quantitative conclusions of failure rates, such as clip migration, nonvisualization, and positive margins.
Sonography has become more accessible for use by clinicians in many fields of medicine. In some breast centers, surgeons use breast sonography routinely in breast clinics as well as intraoperatively. 6 Sonographically detectable clips may help the breast surgeon use intraoperative sonography safely and efficiently. In centers where the use of sonography by surgeons is being introduced, the preoperative placement of sonographically detectable clips may encourage the use of sonography earlier in the learning curve.
Performing a sentinel lymph node biopsy before neoadjuvant chemotherapy, which is done usually under general anesthesia, has become less common lately. 9 This was a circumstance with an advantage to sonographically detectable clip insertion in the tumor by the surgeon. In other instances, clip insertion is best done by the radiologist, who selects the type of clip to be used. The use of sonographically detectable clips by radiologists is growing slowly but is still not very common in our institution, hence the relatively small number of patients in our series.
Preoperative wire localization is associated with pain and discomfort to the patient, which can be avoided by intraoperative tumor localization. In addition, intraoperative tumor localization avoids the dependency of surgical scheduling on the availability of a radiologist. 10 Surgical planning can also be facilitated, since the surgeon is the one who decides on placement of the incision, which can be done without consideration of needle placement. Rates of uninvolved margins are improved by intraoperative sonography in both palpable 10 and nonpalpable 11 lesions. Reoperation rates as low as 4% have been reported in large series. 1 The technique is very safe in experienced hands, with close to a 100% success rate for tumor localization. 9, [12] [13] [14] [15] The use of sonographically detectable clips enables intraoperative sonographic localization when the target lesion itself is not detectable sonographically. In this situation, the clips transform the tumor into a lesion that is easily detectable by sonography. The clips can also aid in intraoperative localization of lesions that are very small or surrounded by multiple radiologic findings. In these situations, the presence of a sonographically detectable clip in the target lesion enhances the accuracy of localization by the surgeon.
Intraoperative sonography may be more effective in localization of breast tumors and in obtaining clear surgical margins than other localization methods. 1, 4, 8, [12] [13] [14] [15] [16] [17] [18] An added benefit of intraoperative sonography is that time can be saved by verification of the presence of the tumor or sonographically detectable clip in the surgical specimen on the operating table in real time, instead of relying on a specimen radiograph when the tumor is detectable mammographically or waiting for a specimen sonogram from a radiologist. Intraoperative localization may also be effectively performed by using radioactive material inserted into the lesion to be removed. 19, 20 This procedure also necessitates localization of the lesion and injection before surgery by the radiologist, although this process can be done several days before the operation, which makes scheduling easier than with wire localization. When a radioactive seed is used, protocols for recovery and disposal of the radioactive material are required. Still, this method is doubtlessly effective for localization and has proved to be at least noninferior to wire localization. 21 These procedures may also be cumbersome because they necessitate localization of the lesion and injection before surgery. Injection may be performed some days before the operation, but the surgery still relies on preoperative localization and radiologic confirmation of lesion resection.
Improved imaging techniques and neoadjuvant treatment have engendered situations in which there might be complete excision of the lesion by vacuum-assisted largecore biopsies, a complete radiologic response to neoadjuvant treatment, or the need to observe lesions detected across different imaging modalities. Tissue markers that can be left in place, especially at the time of percutaneous breast biopsy, have provided solutions in these situations. Since preoperative sonographic localization is easier and less expensive than mammographic localization sonographically detectable clips may be a better option. In cases of non-mass-forming ductal carcinoma in situ, it may be possible to localize the tumor using sonography if a clip has been inserted during stereotactic biopsy. The localization can be done easily either preoperatively by the radiologist or by the surgeon during the operation. This advantage has long been shown by others. 22 The same is true for patients with tumors that are clipped with ultrasound guidance before neoadjuvant chemotherapy who subsequently have a complete radiologic response. The advantages of sonographically detectable clips in postneoadjuvant breast-conserving surgery were recently shown by Ramos et al. 23 When a lesion is detectable solely by MRI, sonographically detectable clip deployment can again simplify subsequent localization. Postneoadjuvant localization in the situation of a residual tumor that is not adjacent to the clip may be especially problematic and should be preoperatively performed by the radiologist.
Another situation in which sonographically detectable clips may be useful is in patients with proven involvement of axillary nodes in the setting of neoadjuvant chemotherapy. It has been suggested that clips can be used in targeted axillary dissection. This procedure involves placing a clip in a lymph node that is known to be positive before neoadjuvant chemotherapy. After completion of chemotherapy, the clipped node is localized by using a wire or radioactive seed, and during the sentinel lymph node dissection procedure, all sentinel nodes and the clipped node are removed. Preoperative wire or radioactive seed insertion may reduce the possibility of false-negative postchemotherapy axillary assessment results by sentinel node biopsy and reduce the number of axillary dissections performed. 24 This step (wire or radioactive seed insertion) becomes unnecessary if a sonographically detectable clip is used and identified on intraoperative sonography.
There are a number of potential problems associated with the use of clips generally and sonographically detectable clips specifically. Clip migration is one of these. One study reported a clip migration rate of 6.4% between clip insertion and the surgical procedure. 25 In other reports, sonographically detectable clips have been said to migrate at rates similar to those of regular clips 26 or less. 27 It is necessary to verify that clip migration has not occurred before the operation. This process may be done by correlating data regarding the distance from the nipple and direction, depth, shape, and size of the tumor with prior written reports as well as referring to previous sonograms. In other instances, the lesion may be marked on the skin by a radiopaque marker for mammographic correlation. The surgeon can also do the preoperative sonography in collaboration with the radiologist, and localization by the radiologist may then be scheduled if difficulties are encountered by the surgeon. However the localization is performed, this close collaboration between the breast surgeon and the breast radiologist is mandatory. This collaboration starts from the initial patient assessment and patient selection for intraoperative localization with or without sonographically detectable clips. During the learning curve for breast sonography by the surgeon, sonographically detectable clips add an additional element to improve cooperation and interaction between the breast radiologist and the breast surgeon.
Another potential problem is that the time when sonographically detectable clips maintain their sonographic detectability varies according to the clip composition. This factor is pivotal if sonography is to be used in the neoadjuvant setting and in the situation of longterm follow-up of lesions that do not mandate immediate surgical excision, even though they maintain their mammographic detectability. Differences in the time when the clips are detectable by sonography have been documented. Of 5 commercially available sonographically detectable clips, different clips were better detected immediately after and 12 weeks after insertion. 28 In some clips, decreases in sonographic detectability at the first office visit and at surgery were observed, suggesting decreasing detectability over a few weeks. 29 Clips containing pellets composed of poly(lactide-co-glycolide) were reported to provide sonographic visibility for only 4 weeks before absorption. 22 An intraoperative detection rate of 93.6% was reported for the hydrogel-based clip that was used in this study 25 but with a high rate of extrusion of the clip when the biopsy tract was transected. There are references to long durability of the HydroMARK clip on websites (eg, http://www.mammotome.com/HydroMARK-2/). In this series, in 9 patients, the clips were easily detectable 140 to 187 days after insertion, even though the manufacturer ensures detectability for 6 weeks (https://www.accessdata.fda. gov/cdrh_docs/pdf13/K130537.pdf).
An additional potential difficulty is the formation of microcalcifications as reactions to hygroscopic materials in sonographically detectable clips that are left in place for a long time. We did not encounter calcifications related to clips in the patients treated by neoadjuvant therapy. However, during long-term follow-up of lesions proven to be nonmalignant, the development of calcifications may present a problem. It seems reasonable at this point to use sonographically detectable clips in instances in which the probability of the need for surgical resection is high, until the rate of such calcification formation is clarified and the degree of certainty of its nature on imaging is better understood. As newer inert clips are developed, this potential problem, if at all clinically important, should be resolved.
In the era of intraoperative sonography, sonographically detectable clips are easily seen by the surgeon and may be safely used in a variety of settings. They can be helpful in primary surgery of nonpalpable breast cancers as well as after neoadjuvant chemotherapy. They can be used to mark breast lesions and lymph nodes. They may remain visible on sonography over many months. With the use of sonographically detectable clips, preoperative wire guide insertion and scheduling difficulties can often be avoided.
